Starting from phytosterols, we will produce various steroid hormones intermediates and APIs through bio-fermentation and chemical synthesis to supply the global market.
Norchem's subsidiary Hunan Chengda Pharmaceutical Co., Ltd., has been committed to the development of the veterinary medicine industry for many years. In 2022, it acquired Shanghai Jisheng Biotechnology to develop large animal reproductive control drugs and pet medicine in all aspects.
Using synthetic biology principles and technical means to achieve the production of specific active substances. Using biomass/starch/glucose as starting materials and synthesizing specialty compounds from biology.
WeChat
Mobile website
